Literature DB >> 10471058

Cytochrome P450 CYP2D6 genotypes: association with hair colour, Breslow thickness and melanocyte stimulating hormone receptor alleles in patients with malignant melanoma.

R C Strange1, T Ellison, F Ichii-Jones, J Bath, P Hoban, J T Lear, A G Smith, P E Hutchinson, J Osborne, B Bowers, P W Jones, A A Fryer.   

Abstract

We previously identified associations between polymorphism in the cytochrome P450 CYP2D6 gene and outcome in several cancers. We have now examined the hypothesis that homozygosity for the mutant alleles, CYP2D6*4 and CYP2D6*3, is associated with susceptibility and outcome in malignant melanoma. Outcome was assessed by Breslow thickness. We first confirmed previous reports that these mutant alleles are associated with increased susceptibility to malignant melanoma. For example, the frequency of homozygosity for CYP2D6*4 was significantly greater (P = 0.006, chi-squared 1 d.f. = 7.4, odds ratio 2.2, 95% confidence interval 1.2, 3.9) in cases (9.1%) than in control individuals (4.3%). The frequency of homozygosity for the mutant alleles was next examined in the malignant melanoma cases grouped on the basis of characteristics associated with malignant melanoma risk. Homozygosity was significantly more common (P = 0.038) in cases with red/blonde hair than in those with brown/black hair. We found no associations between the CYP2D6 genotype and sex, skin type or eye colour. The possible association of CYP2D6 with outcome was assessed by comparing genotype frequencies in patients with tumours of Breslow thickness < 1.5 mm with those whose tumours were > or = 1.5 mm. In patients with red/blonde, but not brown or black hair, homozygosity for CYP2D6*4 was significantly associated with thicker lesions in a multivariate model (P = 0.036). We further examined the association of CYP2D6*4 homozygosity with red/blonde hair by classifying patients on the basis of homo- or heterozygosity for wild-type or val92met, asp294his or asp84glu melanocyte stimulating hormone receptor (MC1R) alleles. None of the nine patients with brown/black hair with the asp294his allele were homozygotes for CYP2D6*4. By contrast, in the patients with red/blonde hair, three of five cases with asp294his were homozygotes for the mutant CYP2D6 allele. The difference in the frequency of CYP2D6*4 homozygotes in the red/blonde cases with wild-type MC1R alleles compared with those with asp294his was significant (exact P = 0.029). No associations between val92his or asp84glu and CYP2D6 alleles were identified.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471058

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  10 in total

1.  CYP2D6*4 allele and breast cancer risk: is there any association?

Authors:  Ana Fernández-Santander; Miguel del Saz Sánchez; Armando Tejerina Gómez; Fernando Bandrés Moya
Journal:  Clin Transl Oncol       Date:  2012-02       Impact factor: 3.405

Review 2.  Genetic determinants of cutaneous melanoma predisposition.

Authors:  Durga Udayakumar; Bisundev Mahato; Michele Gabree; Hensin Tsao
Journal:  Semin Cutan Med Surg       Date:  2010-09

Review 3.  Germline determinants of clinical outcome of cutaneous melanoma.

Authors:  Matjaz Vogelsang; Melissa Wilson; Tomas Kirchhoff
Journal:  Pigment Cell Melanoma Res       Date:  2015-11-03       Impact factor: 4.693

4.  Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies.

Authors:  Sara Raimondi; Sara Gandini; Maria Concetta Fargnoli; Vincenzo Bagnardi; Patrick Maisonneuve; Claudia Specchia; Rajiv Kumar; Eduardo Nagore; Jiali Han; Johan Hansson; Peter A Kanetsky; Paola Ghiorzo; Nelleke A Gruis; Terry Dwyer; Leigh Blizzard; Ricardo Fernandez-de-Misa; Wojciech Branicki; Tadeusz Debniak; Niels Morling; Maria Teresa Landi; Giuseppe Palmieri; Gloria Ribas; Alexander Stratigos; Lynn Cornelius; Tomonori Motokawa; Sumiko Anno; Per Helsing; Terence H Wong; Philippe Autier; José C García-Borrón; Julian Little; Julia Newton-Bishop; Francesco Sera; Fan Liu; Manfred Kayser; Tamar Nijsten
Journal:  BMC Med Res Methodol       Date:  2012-08-03       Impact factor: 4.615

5.  NBN Gene Polymorphisms and Cancer Susceptibility: A Systemic Review.

Authors:  Francesco Berardinelli; Alessandra di Masi; Antonio Antoccia
Journal:  Curr Genomics       Date:  2013-11       Impact factor: 2.236

6.  Genome-Wide Association Studies Provide Insight Into the Genetic Determination for Hyperpigmentation of the Visceral Peritoneum in Broilers.

Authors:  Guangyuan Zhou; Tianfei Liu; Yan Wang; Hao Qu; Dingming Shu; Xinzheng Jia; Chenglong Luo
Journal:  Front Genet       Date:  2022-03-01       Impact factor: 4.599

7.  Polymorphisms of the BRAF gene predispose males to malignant melanoma.

Authors:  Peter Meyer; Consolato Sergi; Claus Garbe
Journal:  J Carcinog       Date:  2003-11-14

8.  Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma.

Authors:  N Soufir; J J Lacapere; G Bertrand; E Matichard; R Meziani; D Mirebeau; V Descamps; B Gérard; A Archimbaud; L Ollivaud; F Bouscarat; M Baccard; G Lanternier; P Saïag; C Lebbé; N Basset-Seguin; B Crickx; H Cave; B Grandchamp
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

9.  Association Between Parkinson's Disease and Melanoma: Putting the Pieces Together.

Authors:  Qing Ye; Ya Wen; Nasser Al-Kuwari; Xiqun Chen
Journal:  Front Aging Neurosci       Date:  2020-03-10       Impact factor: 5.750

Review 10.  Pleiotropic Functions of Cytochrome P450 Monooxygenase-Derived Eicosanoids in Cancer.

Authors:  Ying Luo; Jun-Yan Liu
Journal:  Front Pharmacol       Date:  2020-10-29       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.